Field Notes #1: Psychiatrists, Regulators, Ibogaine, and the Race for Psilocybin Approval

Today, we’re introducing Field Notes.

Field Notes are timely, candid voice notes from our Founder and Editor, Josh Hardman, that provide our Pα+ readers with a pulse on the recent developments in psychedelic drug development, policy, and access in under fifteen minutes.

Rather than publishing these audio clips on a set schedule, we will do so when our on-the-ground reporting and conversations with folks around the field may warrant one.

In our first Field Note, Josh discusses:

• The American Psychiatric Association’s annual meeting in San Francisco
• The ibogaine world, post-executive order
• FDA-related developments, including leadership changes and the race to approval for two psilocybin drug developers, Compass Pathways and Usona Institute
• A broader read on sentiment in the U.S.